Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Association Between Primary Aldosteronism and Cognitive Dysfunction

NCT07304674 is registered in ClinicalTrials.gov with Xinjiang Medical University as lead sponsor.

NCT NCT07304674
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07304674 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Association Between Primary Aldosteronism and Cognitive Dysfunction
Lead sponsor
Xinjiang Medical University
Phase
Observational
Overall status
Recruiting
Start date
December 31, 2025
Completion date
December 31, 2031
Enrollment
1,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive dysfunction, dementia, mild cognitive impairment (mci), primary aldosteronism